Science Day at MUMC+ On April 2, Kjell van der Walle and Paul Kruithof gave a poster presentation during the Science Day at MUMC+

Paul presented the progress of the Osiboost 2A clinical trial (Trial in progress: Personalized Osimertinib dose adjustment and pharmacokinetic boosting to improve cost-effectiveness in advanced EGFR-mutated Non-Small Cell Lung Cancer treatment).
Kjell’s research, "The incidence of diuretic-associated sequential prescribing cascades: a feasibility study," focused on identifying prescribing cascades related to diuretics. Both presentations were well received and both speakers received excellent feedback on their research.

Close the survey
Geef uw mening over de website, of vertel ons hoe wij onze website kunnen verbeteren.
The following privacy and terms of service links belong to Google's reCAPTCHA plugin.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.